A carregar...
Pazopanib in advanced soft tissue sarcomas
Pazopanib is the first and only tyrosine kinase inhibitor currently approved for the treatment of multiple histological subtypes of soft tissue sarcoma (STS). Initially developed as a small molecule inhibitor of vascular endothelial growth factor receptors, preclinical work indicates that pazopanib...
Na minha lista:
| Publicado no: | Signal Transduct Target Ther |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Nature Publishing Group UK
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6522548/ https://ncbi.nlm.nih.gov/pubmed/31123606 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41392-019-0049-6 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|